First Trust Nasdaq Pharmaceuticals ETF FTXH
44.12 USD +0.69 (+1.59%)
Nov 9, 2026, 11:28 AM EST
43.54 Day range 44.12
30.20 52-week range 45.10
- YTD
- +33.94%
- 1 year
- +46.29%
- Market cap
- 1.18B
- EPS (ttm)
- 1.69
- P/E ratio
- 26.15
- YTD return
- +33.94%
- 1-year return
- +46.29%
- Volume
- 37.32K
- Avg volume
- 166.07K
- Open
- 43.90
- Previous close
- 43.43
- Day's range
- 43.54 – 44.12
- 52-week range
- 30.20 – 45.10
5Y +16.25 (+59.79%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 41.80
- 200-day average
- 37.40
About First Trust Nasdaq Pharmaceuticals ETF
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
News
Why Is Eli Lilly Stock Falling Tuesday? 
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' 
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs 
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' 
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms 
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing 
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' 
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' 
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies 
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
Your note
Sign in to keep a note on FTXH — it syncs with the Stock Master app.